Company Overview
Snapshot
Founded in January 2012 by Vadim Shmukler and Nir Israeli, EyeOP operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its diagnostic solutions.
Business overview
EyeOP is a Health Tech & Life Sciences company focused on improving glaucoma diagnosis. The company offers a method for intraocular pressure (IOP) measurement specifically designed for patients in a lying down position, which significantly enhances the diagnostic accuracy and facilitates timely treatment for glaucoma. Its core product is a system comprising a modified ophthalmic surgical bed with a slit lamp and headrest, enabling IOP measurement using a Goldmann applanation tonometer (GAT). EyeOP serves the medical devices industry, targeting healthcare providers and clinics globally with its non-invasive diagnostic solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is EyeOP's primary focus?
- EyeOP focuses on developing a method for intraocular pressure (IOP) measurement for glaucoma diagnosis, particularly for patients in a lying down position to improve diagnostic accuracy.
- When was EyeOP founded?
- EyeOP was founded in January 2012.
- Who are the founders of EyeOP?
- EyeOP was co-founded by Vadim Shmukler and Nir Israeli.
- What is the current product stage of EyeOP?
- EyeOP's product, a system for intraocular pressure measurement using a Goldmann applanation tonometer (GAT), is currently in the Clinical Trial stage.
- What markets does EyeOP target?
- EyeOP targets global markets within the medical devices industry, specifically focusing on healthcare providers and clinics.